|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Independent Control of Mycobacterium tuberculosis Infection Both In Vitro and In Vivo
Laboratory of Mycobacterial Diseases and Cellular Immunology, Division of Bacterial, Parasitic, and Allergenic Products, Center for Biologics Evaluation and Research/Food and Drug Administration, Rockville, MD 20852
Although IFN-
is necessary for survival of Mycobacterium tuberculosis infection in people and animal models, it may not be sufficient to clear the infection, and IFN-
is not a reliable correlate of protection. To determine whether IFN-
-independent mechanisms of immunity exist, we developed a murine ex vivo culture system that directly evaluates the ability of splenic or lung lymphocytes to control the growth of M. tuberculosis within infected macrophages, and that models in vivo immunity to tuberculosis. Surprisingly, CD4+ T cells controlled >90% of intracellular M. tuberculosis growth in the complete absence of IFN-
stimulation of macrophages, via a NO-dependent mechanism. Furthermore, bacillus Calmette-Guerin-vaccinated IFN-
-deficient mice exhibited significant protection against M. tuberculosis challenge that was lost upon depletion of CD4+ T cells. These findings demonstrate that CD4+ T cells possess IFN-
-independent mechanisms that can limit the growth of an intracellular pathogen and are dominant in secondary responses to M. tuberculosis.
This article has been cited by other articles:
![]() |
T. Einarsdottir, E. Lockhart, and J. L. Flynn Cytotoxicity and Secretion of Gamma Interferon Are Carried Out by Distinct CD8 T Cells during Mycobacterium tuberculosis Infection Infect. Immun., October 1, 2009; 77(10): 4621 - 4630. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Parra, A. L. Yang, J. Lim, K. Kolibab, S. Derrick, N. Cadieux, L. P. Perera, W. R. Jacobs, M. Brennan, and S. L. Morris Development of a Murine Mycobacterial Growth Inhibition Assay for Evaluating Vaccines against Mycobacterium tuberculosis Clin. Vaccine Immunol., July 1, 2009; 16(7): 1025 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bertholet, G. C. Ireton, M. Kahn, J. Guderian, R. Mohamath, N. Stride, E. M. Laughlin, S. L. Baldwin, T. S. Vedvick, R. N. Coler, et al. Identification of Human T Cell Antigens for the Development of Vaccines against Mycobacterium tuberculosis J. Immunol., December 1, 2008; 181(11): 7948 - 7957. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Price, K. R. Simpfendorfer, R. R. Mantena, J. Holden, W. R. Heath, N. van Rooijen, R. A. Strugnell, and O. L. C. Wijburg Gamma Interferon-Independent Effects of Interleukin-12 on Immunity to Salmonella enterica Serovar Typhimurium Infect. Immun., December 1, 2007; 75(12): 5753 - 5762. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Cowley, J. D. Sedgwick, and K. L. Elkins Differential Requirements by CD4+ and CD8+ T Cells for Soluble and Membrane TNF in Control of Francisella tularensis Live Vaccine Strain Intramacrophage Growth J. Immunol., December 1, 2007; 179(11): 7709 - 7719. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Wolf, B. Linas, G. J. Trevejo-Nunez, E. Kincaid, T. Tamura, K. Takatsu, and J. D. Ernst Mycobacterium tuberculosis Infects Dendritic Cells with High Frequency and Impairs Their Function In Vivo J. Immunol., August 15, 2007; 179(4): 2509 - 2519. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Cowley, E. Hamilton, J. A. Frelinger, J. Su, J. Forman, and K. L. Elkins CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo J. Exp. Med., July 18, 2005; 202(2): 309 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Feng, D. Jankovic, M. Kullberg, A. Cheever, C. A. Scanga, S. Hieny, P. Caspar, G. S. Yap, and A. Sher Maintenance of Pulmonary Th1 Effector Function in Chronic Tuberculosis Requires Persistent IL-12 Production J. Immunol., April 1, 2005; 174(7): 4185 - 4192. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |